Open | $4.890 |
Close | $4.755 |
Volume / Avg. | 352.222K / 754.990K |
Day Range | 4.670 - 4.900 |
52 Wk Range | 3.800 - 10.270 |
Market Cap | $148.384M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 17.01% |
Days to Cover | 10.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of PDS Biotechnology (NASDAQ: PDSB) through any online brokerage.
Other companies in PDS Biotechnology’s space includes: Zura Bio (NASDAQ:ZURA), Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), CytomX Therapeutics (NASDAQ:CTMX) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for PDS Biotechnology (NASDAQ: PDSB) was reported by Oppenheimer on Wednesday, November 15, 2023. The analyst firm set a price target for 20.00 expecting PDSB to rise to within 12 months (a possible 319.29% upside). 13 analyst firms have reported ratings in the last year.
The stock price for PDS Biotechnology (NASDAQ: PDSB) is $4.77 last updated March 18, 2024 at 6:57 PM EDT.
There are no upcoming dividends for PDS Biotechnology.
PDS Biotechnology’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for PDS Biotechnology.
PDS Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.